Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years

JAMA

Volumn 296, Issue 24, 2006, Pages 2939-2946

  Carandang, Raphael ^a   Seshadri, Sudha ^a,c   Beiser, Alexa ^b   Kelly Hayes, Margaret ^a,c   Kase, Carlos S ^a,c   Kannel, William B ^c   Wolf, Philip A ^a,c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c FRAMINGHAM HEART STUDY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN ATHEROSCLEROSIS; BRAIN INFARCTION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; STROKE;

EID: 33845866055     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.296.24.2939     Document Type: Article

References (56)

1. Wolf PA. Epidemiology of stroke. In: Mohr JP, Choi DW, Grotta JC, Weir B, Wolf PA, eds. Stroke: Pathophysiology, Diagnosis, and Management. 4th ed. Philadelphia, Pa: Churchill Livingstone; 2004:13-34.
2. American Heart Association. Heart Disease and Stroke Statistics - 2006 Update. Dallas, Tex: American Heart Association; 2006.
3. Broderick J, Brott T, Kothari R, et al. The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first ever and total incidence rates of stroke among blacks. Stroke. 1998;29:415-421.
4. Kwan J. Clinical epidemiology of stroke. CME J Geriatr Med. 2001;3:94-98.
5. Rothwell PM, Coull AJ, Giles MF, et al; Oxford Vascular Study. Change in stroke incidence, mortality, case-fatality, severity and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet. 2004;363:1925-1933.
6. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
7. Furlan A, Higashida R, Weschler L, et al. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized, controlled trial. JAMA. 1999;282:2003-2011.
8. Stegmayr B, Asplund K, Hulter-Asberg K, et al. Stroke units in their natural habitat: can results of randomized trials be reproduced in routine clinical practice? Stroke. 1999;30:709-714.
9. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke. 1991;22:312-318.
10. MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomized controlled trial. Lancet. 2004;363:1491-1502.
11. Goldstein LB, Adams R, Becker K, et al. Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke. 2001;32:280-299.
12. Ridker PM, Cook NR, Lee IM, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med. 2005;352:1293-1304.
13. PROGRESS Collaborative Group. Randomized trial of a perindopril-based blood pressure lowering regimen among 6105 individuals with previous stroke or transient ischemic attack. Lancet. 2001;358:1033-1041.
14. Diener HC, Cunha L, Forbes C, et al; European Stroke Prevention Study 2 (ESPS2). Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci. 1996;143:1-13.
15. Cholesterol Treatment Trialists'(CTT) Collaborators. Efficacy and safety of cholesterol lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomized trials. Lancet. 2005;366:1267-1278.
16. Seshadri S, Beiser A, Kelly-Hayes M, et al. The lifetime risk of stroke: estimates from the Framingham Study. Stroke. 2006;37:345-350.
17. Dawber TR, Meadors GF, Moore FE Jr. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health. 1951;41:279-281.
18. Broderick JP. Stroke trends in Rochester, Minnesota, during 1945 to 1984. Ann Epidemiol. 1993;3:476-479.
19. Broderick JP, Phillips SJ, Whisnant JP, O'Fallon WM, Bergstralh EJ. Incidence rates of stroke in the eighties: the end of the decline in stroke? Stroke. 1989;20:577-582.
20. Drury I, Whisnant JP, Garraway WM. Primary intracerebral hemorrhage: impact of CT on incidence. Neurology. 1984;34:653-657.
21. Beiser A, D'Agostino RB Sr, Seshadri S, Sullivan LM, Wolf PA. Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study: the Practical Incidence Estimators (PIE) macro. Stat Med. 2000;19:1495-1522.
22. Kagan A, Popper J, Reed DM, Maclean CJ, Grove JS; the Honolulu Heart Program. Trends in stroke incidence and mortality in Hawaiian Japanese men. Stroke. 1994;25:1170-1175.
23. Cheng XM, Ziegler DK, Lai YH, et al. Stroke in China, 1986 through 1990. Stroke. 1995;26:1990-1994.
24. Thorvaldsen P, Davidsen M, Bronnum-Hansen H, Schroll M; Danish MONICA Study Group. Stable stroke occurrence despite incidence reduction in an aging population: stroke trends in the Danish Monitoring Trends and Determinants in Cardiovascular Disease (MONICA) population. Stroke. 1999;30:2529-2535.
25. Jamrozik K, Broadhurst R, Hankey G, Burvill P, Anderson C. Trends in the incidence, severity and short-term outcome of stroke in Perth, Western Australia. Stroke. 1999;30:2105-2111.
26. Morikawa Y, Nakagawa H, Naruse Y, et al. Trends in stroke incidence and acute case fatality in a Japanese rural area: the Oyabe Study. Stroke. 2000;31:1583-1587.
27. Kubo M, Kiyohara Y, Kato I, et al. Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: the Hisayama Study. Stroke. 2003;34:2349-2354.
28. Kubo M, Kiyohari Y, Ninomiya T, et al. Decreasing incidence of lacunar vs other types of cerebral infarction in a Japanese population. Neurology. 2006;66:1539-1544.
29. Numminen H, Kotila M, Waltimo O, Aho K, Kaste M. Declining incidence and mortality rates of stroke in Finland from 1972 to 1991: results of three population-based stroke registers. Stroke. 1996;27:1487-1491.
30. Sivenius J, Tuomilehto P, Immonen-Raiha P, et al. Continuous 15-year decrease in incidence and mortality of stroke in Finland: the FINSTROKE Study. Stroke. 2004;35:420-425.
31. Anderson CS, Carter KN, Hackett ML, et al; Auckland Regional Community Stroke (ARCOS) Study Group. Trends in stroke incidence in Auckland, New Zealand, during 1981 to 2003. Stroke. 2005;36:2087-2093.
32. Benatru I, Rouaud O, Durier J, et al. Stable stroke incidence rates but improved case fatality in Dijon, France, from 1985-2004. Stroke. 2006;37:1674-1679.
33. Eisenblatter D, Heinemann L, Classen E. Community-based stroke incidence trends from the 1970s through the 1980s in East Germany. Stroke. 1995;26:919-923.
34. Cooper R, Sempos C, Hsieh SC, Kovar MG. Slow-down in the decline of stroke mortality in the United States, 1978-1986. Stroke. 1990;21:1274-1279.
35. Shahar E, McGovern P, Pankow J, et al. Stroke rates during the 1980s: the Minnesota Stroke Survey. Stroke. 1997;28:275-279.
36. Hollander M, Koudstaal PJ, Bots ML, Grobbee DE, Hofman A, Breteler MM. Incidence, risk, and case fatality of first ever stroke in the elderly population: the Rotterdam Study. J Neurol Neurosurg Psychiatry. 2003;74:317-321.
37. Wolf PA, D'Agostino RB, O'Neal MA, et al. Secular trends in stroke in the Framingham Study. Stroke. 1992;23:1551-1555.
38. Kelly-Hayes M, Beiser A, Kase CS, D'Agostino R, Scaramucci A, Wolf PA. The influence of gender and age on disability following ischemic stroke: the Framingham Study. J Stroke Cerebrovasc Dis. 2003;12:119-126.
39. Nakayama H, Jogensen HJ, Schou R, Olsen TS. The influence of age on stroke outcome: the Copenhagen Stroke Study. Stroke. 1994;25:808-813.
40. Kapral MK, Fang J, Hill MD, et al. Sex differences in stroke care and outcomes: results from the registry of the Canadian Stroke Network. Stroke. 2005;36:809-814.
41. Lauria G, Gentile M, Fassetta G, et al. Incidence and prognosis of stroke in Belluno Province, Italy: first-year results of a community-based study. Stroke. 1995;26:1787-1793.
42. Thrift AG, Dewey HM, Macdonell RA, McNeill JJ, Donnan GA. Incidence of the major stroke subtypes: initial findings from North East Melbourne Stroke Incidence Study (NEMESIS). Stroke. 2001;32:1732-1738.
43. Smadja D, Cabre P, May F, et al; ERMANCIA Study Group. ERMANCIA: epidemiology of stroke in Martinique, French West Indies: part I: methodology, incidence and 30-day case fatality rate. Stroke. 2001;32:2741-2747.
44. Carolei A, Marini C, Di Napoli M, et al. High stroke incidence in the prospective community-based L'Aquila Registry (1994-1998): first year's results. Stroke. 1997;28:2500-2506.
45. Johansson B, Norrvig B, Lindgren A. Increased stroke incidence in Lund-Orup, Sweden, between 1983 to 1985 and 1993 to 1995. Stroke. 2000;31:481-486.
46. Bonita R, Borad JB, Beaglehole R. Changes in stroke incidence and case fatality in Auckland, New Zealand, 1981-91. Lancet. 1993;342:1470-1473.
47. Pessah-Rasmussen H, Engstrom G, Jerntorp I, Janzon L. Increasing stroke incidence and decreasing case fatality 1989-1998: a study from the stroke register in Malmo, Sweden. Stroke. 2003;34:913-918.
48. Harmsen P, Tsipogianni A, Wilhemsen L. Stroke incidence rates were unchanged, while fatality rates declined, during 1971-1987 in Goteborg, Sweden. Stroke. 1992;23:1410-1415.
49. Hallstrom B, Norrving B, Lindgren A. Stroke in Lund-Orup, Sweden: improved long-term survival among elderly stroke patients. Stroke. 2002;33:1624-1629.
50. Howard G, Howard V, Katholi C, Oli M, Huston S. Decline in US stroke mortality: an analysis of temporal patterns by sex, race, and geographic region. Stroke. 2001;32:2213-2218.
51. Sarti C, Rastenyte D, Cepaitis Z, Tuomilehto J. International trends in mortality from stroke, 1968-1994. Stroke. 2000;31:1588-1601.
52. Derby CA, Lapane KL, Feldman HA, Carleton RA. Trends in validated cases of fatal and nonfatal stroke, stroke classification, and risk factors in southeastern New England, 1980 to 1991: data from the Pawtucket Heart Health Program. Stroke. 2000;31:875-881.
53. Fang J, Alderman M. Trend of stroke hospitalization, United States 1988-1997. Stroke. 2001;32:2221-2226.
54. Fogelholm R. Explanations for international trends in stroke mortality. Stroke. 2003;34:1840-1841.
55. Muntner P, Garrett E, Klag MJ, Coresh J. Trends in stroke prevalence between 1973 and 1991 in the US population 25 to 74 years of age. Stroke. 2002;33:1209-1213.
56. Thorvaldsen P, Asplund K, Kuulasma K, Rajakangas A, Schroll M. Stroke incidence, case fatality and mortality in the WHO MONICA Project. Stroke. 1995;26:361-367.